Previous close | 15.00 |
Open | 15.00 |
Bid | 15.80 |
Ask | 16.60 |
Strike | 430.00 |
Expiry date | 2024-06-21 |
Day's range | 15.00 - 15.00 |
Contract range | N/A |
Volume | |
Open interest | 110 |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning